Allergen-specific immunotherapy: An update on immunological mechanisms of action

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 65, Issue 1, 2006, Pages 34-37

  Ciprandi, Giorgio ^a   Marseglia, G L ^b   Tosca, M A ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Allergen specific immunotherapy; Atopy; IgE; IgG4

Indexed keywords

ALLERGEN; ANTIBODY; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10;

ALLERGY; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOTHERAPY; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 33646433428     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2006.583     Document Type: Review

References (28)

1. Lockey RF. "ARIA": Global guidelines and new forms of allergen immunotherapy. J Allergy Clin Immunol 2001; 108: 497-9.
2. Lewis DB. Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? Curr Opin Immunol 2002; 14: 644-51.
3. Waldmann TA. Immunotherapy: past, present and future. Nat Med 2003; 9: 269-77.
4. Frew AJ. Immunotherapy of allergic disease. J Allergy Clin Immunol 2003; 111: S712-9.
5. Fasce L, Tosca MA, Olcese R, Milanese M, Erba D, Ciprandi G. The natural history of allergy: the development of new sensitisations in asthmatic children. Immunology Letters 2004; 93: 45-50
6. Busse WW, Rosenwasser LJ. Mechanisms of asthma. J Allergy Clin Immunol 2003; 111: S799-804.
7. Durham SR, Till SJ. Immunological changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102: 157-64.
8. Romagnani S. New therapeutic strategies in allergic diseases. Drugs of Today 2003; 39: 849-65.
9. Frieri M. New frontiers in immunotherapy. Allergy Asthma Proc 1999; 20: 281-8.
10. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003; 111: 437-48.
11. Ippoliti F, De Sanctis W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children. Ped Allergy Immunol 2003; 14: 216-21.
12. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga I. Insect venom immunotherapy induces IL10 production and a Th2 to Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997; 27: 586-96.
13. Nasser SM, Ying S, Meng Q, Kay AB, Ewan PW. IL10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. Eur J Immunol 2001; 31: 3704-13.
14. Akdis CA, Blesken T, Akdis M, Wutrich B, Blaser K. Role of IL10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
15. Akdis CA, Blaser K. IL10 induced anergy in peripheral T cells and reaction by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 1999; 13: 603-9.
16. McHugh RS, Shevah EM. The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol 2002; 111: 693-702.
17. Bellinghausen I, Knop J, Saloga J. The role of IL10 in the regulation of allergic immune responses. Int Arch Allergy Immunol 2001; 126: 97-101.
18. Schramm C, Herz U, Podlech J, et al. TGFbeta regulates airway responses via T cells. J Immunol 2003; 170: 1313-9.
19. Koulis A, Robinson DG. The anti-inflammatory effects of IL10 in allergic disease. Clin Exp Allergy 2000; 30: 747-50.
20. Blaser K, Akdis CA. IL10, T regulatory cells and specific allergy treatment. Clin Exp Allergy 2004; 34: 328-31.
21. Savolainen J, Laaksonen K, Rantio-Lehtimski G, Terho EO. Increased expression of allergen-induced in vitro IL10 and IL18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy 2004; 34: 413-9.
22. Homer AA, Van Uden JH, Zubeldia JM, Broide D, Raz E. DNA-based immunotheraputics for the treatment of allergic disease. Immunol Rev 2001; 179: 102-18.
23. Jutel M, Akdis M, Budak F, et al. IL10 and TGFbeta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-14.
24. Passalacqua G. Immunoterapia specifica. In: Zanussi C (Ed). Trattato Italiano di Allergologia. Pavia: Selecta Medica 2002: 1055-73.
25. Fanta C, Bohle B, Hirt W, et al. Systemic immunological changes induced by administartion of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999; 120: 218-24.
26. Fenoglio D, Puppo F, Cirillo I, et al. Sublingual specific immunotherapy reduces PBMC proliferations. Allergol Immunol 2005; 37: 147-51.
27. Ciprandi G, Fenoglio D, Cirillo I, et al. Sublingual HDM-specific immunotherapy induces IL-10 production: preliminary report. Ann Allergy Asthma Immunol 2005; 95; 38-44.
28. Ciprandi G, Fenoglio D, Cirillo I, Milanese M, Minuti P. Sublingual Immunotherapy and Tregs. Allergy 2006; 61: 511-3.